MDL | - |
---|---|
Molecular Weight | 275.30 |
Molecular Formula | C17H13N3O |
SMILES | OC1=CC=CC(NC2=C3C4=CC=CC=C4NC3=NC=C2)=C1 |
Tilfrinib (20 µM; 36 h) shows inhibition of PTK6, and decreases the ETV4 WT-induced expression of CXCL1 or CXCL8 in UM-UC-3 cells and expression of VEGFA or MMP9 in TANs
[1]
.
Tilfrinib (compound 4f) shows good anti-proliferative activity against MCF7, HS-578/T and BT-549 cells with GI
50
values of 0.99, 1.02 and 1.58 µM
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [1]
Cell Line: | UM-UC-3 cells (stably expressing FLAG-ETV4 WT or Y392F) |
Concentration: | 20 µM |
Incubation Time: | 36 h |
Result: | Reduced ETV4 WT-induced expression of CXCL1 or CXCL8 in UM-UC-3 cells and expression of VEGFA or MMP9 in TANs by inhibiting PTK6. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 125 mg/mL ( 454.05 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.6324 mL | 18.1620 mL | 36.3240 mL |
5 mM | 0.7265 mL | 3.6324 mL | 7.2648 mL |
10 mM | 0.3632 mL | 1.8162 mL | 3.6324 mL |